Subtype Classification of Iranian HIV-1 Sequences Registered in the HIV Databases, 2006-2013

K Baesi, 2014, Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran. J Med Virol, 86(7), 1093

DJ Hu, 1996, The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA, 275(3), 210

RJ Lessells, 2012, Are subtype differences important in HIV drug resistance? Curr Opin Virol, 2(5), 636

LM Luft, 2011, HIV-1 viral diversity and its implications for viral load testing: review of current platforms. Int J Infect Dis, 15(10), e661

MA Wainberg, 2012, The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs. Mol Biol Int, 2012, 256982

F Jahanbakhsh, 2013, Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35_AD Predominance and CRF01_AE Infection Among Individuals Associated with Injection Drug Use. AIDS Res Hum Retroviruses, 29(1), 198

National AIDS Committee Secretariat, Ministry of Health and Medical Education (2013) Islamic Republic of Iran AIDS Progress Report: on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS.

F Jahanbakhsh, 2013, Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011. PLoS One, 8(4), e61864

MM Mir-Nasseri, 2011, Incarceration is a major risk factor for blood-borne infection among intravenous drug users. Hepat Monthly, 11(1), 19

K Baesi, 2010, Phylogenetic analysis of HIV-1 pol gene (RT sequences) among Iranian HIV infected patients. Sci J Iran Blood Transfus Org, 7(2), 94

HR Naderi, 2006, Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran. Infect Agent Cancer, 1, 4

R Sarrami-Forooshani, 2006, Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol, 78(7), 853

M Tagliamonte, 2007, HIV type 1 subtype A epidemic in injecting drug user (IDU) communities in Iran. AIDS Res Hum Retroviruses, 23(12), 1569

R Hamkar, 2010, Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients. AIDS, 24, S85

SM Mousavi, 2010, Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study. Arch Virol, 155(3), 329

ZS Soheilli, 2009, Presence of HIV-1 CRF35_AD in Iran. AIDS Res Hum Retroviruses, 25(1), 123

S Kurle, 2004, Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res Hum Retroviruses, 20(10), 1113

RM Lynch, 2009, Appreciating HIV type 1 diversity: subtype differences in Env. AIDS Res Hum Retroviruses, 25(3), 237

M Tongo, 2013, Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic. Virology J, 10, 29

E Castro-Nallar, 2012, The evolution of HIV: Inferences using phylogenetics. Mol Phylogenet Evol, 62(2), 777

E Sanders-Buell, 2007, A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD. AIDS Res Hum Retroviruses, 23(6), 834

E Sanders-Buell, 2010, Distinct circulating recombinant HIV-1 strains among injection drug users and sex workers in Afghanistan. AIDS Res Hum Retroviruses, 26(5), 605